Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 459,014 |
|
|||||
| News | - | ||||||
| Day High | 2.10 | Low High |
|||||
| Day Low | 1.90 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Longeveron Inc | LGVN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0304 | -1.51% | 1.9796 | 19:39:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.92 | 1.90 | 2.10 | 1.92 | 2.01 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,413 | 459,014 | $ 1.97 | $ 902,886 | - | 1.62 - 44.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:56:35 | 3 | $ 1.98 | USD |
Longeveron Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 25.13M | - | 709k | -22.21M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Longeveron News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LGVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.18 | 4.24 | 1.62 | 2.94 | 14,145,615 | -0.2004 | -9.19% |
| 1 Month | 4.04 | 5.47 | 1.62 | 2.61 | 6,713,626 | -2.06 | -51.00% |
| 3 Months | 7.90 | 8.15 | 1.62 | 2.91 | 2,436,358 | -5.92 | -74.94% |
| 6 Months | 18.30 | 23.90 | 1.62 | 3.98 | 1,232,745 | -16.32 | -89.18% |
| 1 Year | 28.00 | 44.00 | 1.62 | 7.99 | 742,059 | -26.02 | -92.93% |
| 3 Years | 64.90 | 450.00 | 1.62 | 140.49 | 1,818,248 | -62.92 | -96.95% |
| 5 Years | 100.00 | 450.00 | 1.62 | 138.18 | 1,782,996 | -98.02 | -98.02% |
Longeveron Description
| Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS). |
